secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0001493152-23-033396
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech to present Ampligen oncology data at Roswell Park symposium
--------------------------------------------------------------------------

- Chris McAleer, Ph.D., Scientific Officer, will present at the Marie Sklodowska-Curie Symposium on Cancer Research and Care at Roswell Park.
- Company also sponsors the symposium; presentation titled 'Rintatolimod (Ampligen): Overview of Ampligen’s Clinical Progress in Oncology'.
- No new clinical results or financial data disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315223033396/0001493152-23-033396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315223033396/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-033396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer